CAPN2 and ovarian carcinoma: There are a large number of differences between studies; the in vitro study investigated calpain modulation in a range of ovarian cancer cell lines at the time of treatment with cisplatin; whereas the current study documents the expression level of calpain-2 in tumours prior to treatment.